A would-be rival to Dying Light and State of Decay, struggling zombie game No More Room in Hell 2 is back to life and ...

BofA lowered the firm’s price target on Illumina (ILMN) to $75 from $90 and keeps an Underperform rating on the shares. Sentiment for Life Sciences and Diagnostic Tools and Contract Research ...

Get a deep dive into what you can expect from No More Room in Hell 2's Reanimation update, which brings two new maps, new ...

Illumina Inc. (NASDAQ: ILMN) and Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration to ...

Activist investor, Carl Icahn, put pressure on the company for management changes, leading to deSouza and Illumina’s previous chairman, John Thompson, to step down in the wake of the Grail ...

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families.

A team at UC Davis has created a new drug called JRT that mimics LSD’s brain-healing effects without the hallucinogenic side ...

But it is an extraordinary step. The Chinese firm Jingye will - on ... With that in mind, it would be politically intolerable to see the UK's last two blast furnaces closed and thousands of ...

Two Harbors Investment Corp. invests in, finances, and manages mortgage servicing rights (MSRs), agency residential mortgage-backed securities (RMBS), and other financial assets through RoundPoint ...

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems ...

Are Guggenheim retrospectives a blessing or a curse for artists? Ross Bleckner shares what happened after his 1995 solo show.